CMS focuses on IP and pharmaceutical advertising law, which the team most recently demonstrated in supporting various national and cross-border transactions, including related regulatory advice, such as merger control matters. Other mainstays of the practice include the advice on medicinal cannabis and product liability as well as the growing support to clients from the digital pharmacy sector in third-party opposition proceedings. Practice head Jens Wagner is experienced in pharmaceutical law, biotechnology and medical devices, where he regularly advises on patent and licensing issues. Matthias Eck retired in 2023.
Testimonials
Collated independently by Legal 500 research team.
'What we particularly value about CMS is its pragmatic and practice-oriented approach, its service orientation, its very high level of technical quality and its extensive industry expertise.'
'For many years, Jens Wagner has successfully managed and coordinated several large international product liability cases and voluntary recalls with his calm and level-headed manner. We value him both as a tough litigator and as a very competent advisor and negotiator. Due to his excellent industry expertise and team orientation, he was able to build a powerful life sciences team around the younger partners and counsel.'